Study: NCT04518228

Intervention type: DRUG
Intervention: Lopinavir/ritonavir (LPV/r)
Description: Administered consistent with the package inserts and/or instructions provided by the non-study sources who prescribe or supply the drugs to participants

Intervention type: DRUG
Intervention: Lopinavir/ritonavir (LPV/r)
Description: Administered consistent with the package inserts and/or instructions provided by the non-study sources who prescribe or supply the drugs to participants

Intervention type: DRUG
Intervention: Cobicistat
Description: Administered consistent with the package inserts and/or instructions provided by the non-study sources who prescribe or supply the drugs to participants

Intervention type: DRUG
Intervention: Cobicistat
Description: Administered consistent with the package inserts and/or instructions provided by the non-study sources who prescribe or supply the drugs to participants

Intervention type: DRUG
Intervention: Ritonavir
Description: Administered consistent with the package inserts and/or instructions provided by the non-study sources who prescribe or supply the drugs to participants

Intervention type: DRUG
Intervention: First-Line TB Treatment
Description: Participants will be receiving first-line TB treatment with at least two of the following TB treatment drugs: isoniazid (INH), rifampin (RIF), rifabutin (RFB), ethambutol (EMB), pyrazinamide (PZA), or moxifloxacin (MFX).~Drugs will be administered consistent with the package inserts and/or instructions provided by the non-study sources who prescribe or supply the drugs to participants.

Intervention type: DRUG
Intervention: First-Line TB Treatment
Description: Participants will be receiving first-line TB treatment with at least two of the following TB treatment drugs: isoniazid (INH), rifampin (RIF), rifabutin (RFB), ethambutol (EMB), pyrazinamide (PZA), or moxifloxacin (MFX).~Drugs will be administered consistent with the package inserts and/or instructions provided by the non-study sources who prescribe or supply the drugs to participants.

Intervention type: DRUG
Intervention: First-Line TB Treatment
Description: Participants will be receiving first-line TB treatment with at least two of the following TB treatment drugs: isoniazid (INH), rifampin (RIF), rifabutin (RFB), ethambutol (EMB), pyrazinamide (PZA), or moxifloxacin (MFX).~Drugs will be administered consistent with the package inserts and/or instructions provided by the non-study sources who prescribe or supply the drugs to participants.

Intervention type: DRUG
Intervention: Second-Line TB Treatment
Description: Participants will be receiving second-line TB treatment with at least one of the following second-line TB treatment drugs:~* Levofloxacin (LFX) 750mg - 1000mg q.d.~* Clofazimine (CFZ) 100mg q.d.~* Linezolid (LZD) 300mg - 600mg q.d.~* Bedaquiline (BDQ) 200mg three times per week (t.i.w.)~* Delamanid (DLM) 100mg b.i.d.~* Moxifloxacin (MFX) 400mg or 800mg q.d., and at least one other second-line TB treatment drug under study~Drugs will be administered consistent with the package inserts and/or instructions provided by the non-study sources who prescribe or supply the drugs to participants.

Intervention type: DRUG
Intervention: Doravirine (DOR)
Description: Administered consistent with the package inserts and/or instructions provided by the non-study sources who prescribe or supply the drugs to participants